These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19210039)

  • 1. Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.
    Almkvist O; Tallberg IM
    Neuropsychology; 2009 Jan; 23(1):117-24. PubMed ID: 19210039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of premorbid cognitive function based on word knowledge: the Swedish Lexical Decision Test (SLDT).
    Almkvist O; Adveen M; Henning L; Tallberg IM
    Scand J Psychol; 2007 Jun; 48(3):271-9. PubMed ID: 17518919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
    Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Education and cognitive function in Alzheimer's disease.
    Filley CM; Cullum CM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jan; 10(1):48-51. PubMed ID: 9118196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin.
    Zhou A; Jia J
    J Int Neuropsychol Soc; 2009 Nov; 15(6):898-905. PubMed ID: 19891819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between behavioural and psychological symptoms of dementia and cognition in Alzheimer's disease.
    Starr JM; Lonie J
    Dement Geriatr Cogn Disord; 2007; 24(5):343-7. PubMed ID: 17890863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
    Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is functional decline necessary for a diagnosis of Alzheimer's disease?
    Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
    Nordlund A; Rolstad S; Klang O; Lind K; Pedersen M; Blennow K; Edman A; Hansen S; Wallin A
    J Int Neuropsychol Soc; 2008 Jul; 14(4):582-90. PubMed ID: 18577287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
    Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
    Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
    Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
    Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
    Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.
    Weiss EM; Kohler CG; Vonbank J; Stadelmann E; Kemmler G; Hinterhuber H; Marksteiner J
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):974-80. PubMed ID: 19038896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
    Jones S; Small BJ; Fratiglioni L; Backman L
    Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.